Expert second opinions for bicuspid aortic valve. Dual-physician Heart Team review with triple risk scoring. Results in 24 hours.
Bicuspid Aortic Valve (BAV) is the most common congenital heart defect, affecting 1-2% of the population. If you are facing a decision about bicuspid aortic valve, an independent Heart Team second opinion can confirm whether surgery is the right choice and identify alternatives. WhiteGloveMD delivers dual-physician review with STS, EuroSCORE II, and AATS risk scoring in 24 hours. Get an independent second opinion →
Bicuspid aortic valve (BAV) is the most common congenital heart defect, affecting 1-2% of the population. Instead of three leaflets, the valve has two, making it prone to stenosis, regurgitation, and associated aortopathy. Many patients with BAV will need surgery during their lifetime, making valve strategy and timing critical decisions.
BAV management requires expertise in congenital valve disease, aortopathy surveillance, and complex valve repair techniques. The Ross procedure — replacing the aortic valve with the patient's own pulmonary valve — offers excellent long-term outcomes in select patients but requires specialized surgical expertise. Most patients are not evaluated for this option.
Surgery for bicuspid aortic valve depends on symptom severity, imaging findings, and risk profile. Guidelines from the AHA/ACC define specific thresholds, but many patients fall into gray zones where a second opinion meaningfully changes the recommendation. BAV management requires expertise in congenital valve disease, aortopathy surveillance, and complex valve repair techniques. The Ross procedure — replacing the aortic valve with the patient's own pulmonary valve — offers excellent long-term outcomes in select patients but requires specialized surgical expertise. Most patients are not evaluated for this option.
Operative mortality for bicuspid aortic valve-related cardiac surgery is calculated using validated models including STS PROM, EuroSCORE II, and AATS. Individual risk depends on age, comorbidities, frailty, ejection fraction, and surgeon/center volume. Our free calculator at whiteglovemd.com/tools/risk-calculator estimates your specific risk across all three models in real time.
Yes. Studies show that 30-40% of expert cardiac surgery second opinions change the original treatment plan — sometimes by recommending less-invasive alternatives, sometimes by clarifying that watchful waiting is safer. WhiteGloveMD pairs a cardiac surgeon and cardiologist with our Clintelligence multi-agent AI pipeline to deliver an independent review in 24 hours, starting at $500.
The optimal treatment for bicuspid aortic valve depends on anatomy, comorbidities, age, and personal goals. Ross procedure candidacy and surgeon selection. A Heart Team review evaluates every viable option — including transcatheter approaches, repair vs replacement, and surgeon/center matching — rather than defaulting to a single recommendation.
WhiteGloveMD delivers a dual-physician, AI-augmented second opinion in 24 hours. Starting at $500.